Supporting Mental Health in Daily Life After the Diagnosis of Multiple Sclerosis - Trial NCT06403631
Access comprehensive clinical trial information for NCT06403631 through Pure Global AI's free database. This phase not specified trial is sponsored by Marta Bassi and is currently Recruiting. The study focuses on Multiple Sclerosis. Target enrollment is 123 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Marta Bassi
University of Milan
Timeline & Enrollment
N/A
Nov 06, 2023
Feb 28, 2026
Primary Outcome
Positive mental health (Mental Health Continuum Short Form),Anxiety (subscale of the Hospital Anxiety and Depression Scale),Depression (subscale of the Hospital Anxiety and Depression Scale)
Summary
The overall goal of this observational study is to learn about the psychological resources of
 mindfulness and flow experience available to persons newly diagnosed with multiple sclerosis
 (MS). The primary study aim will be to analyze the relation of flow and mindfulness with
 mental health among individuals who received an MS diagnosis within the last year. Secondary
 aims will be to analyze the daily activities preferentially associated with flow, and to
 evaluate possible changes in daily flow retrieval. Participants will answer questionnaires
 measuring flow, mindfulness, positive mental health, anxiety and depression at project start
 and 6 months later.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06403631
Non-Device Trial